Ateme S.A.
€12.05+€0.55 (+4.78%)
Ateme S.A.’s quoted price sits in the upper half of its reported 52-week range, 14.54% below the high.
PAR · VANTI.PA · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Vantiva S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Vantiva S.A.’s forward annual dividend is €1.62 per share, paid annual. The forward yield is 2,009.93% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Vantiva S.A.’s next earnings report is currently expected on Mar 11, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vantiva S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Vantiva S.A., an international corporation based in France, focuses on providing technology solutions and services for the communication, media, and entertainment industries. Although headquartered in Paris, the company extends its operations through offices located in Rennes, Beijing, Seoul, Chennai, Edegem, Norcross, and Manaus.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2023 | Jul 27, 2023 | -€0.64 | €1.04B0.0% vs estimate |
|---|
| Q4 2022 | Mar 9, 2023 | -€0.75 | €791.50M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€12.05+€0.55 (+4.78%)
Ateme S.A.’s quoted price sits in the upper half of its reported 52-week range, 14.54% below the high.
€6.63+€0.31 (+4.91%)
Riber S.A.’s quoted price sits in the lower half of its reported 52-week range, 64.16% below the high.
€16.50+€0.75 (+4.76%)
LACROIX Group S.A.’s quoted price sits in the upper half of its reported 52-week range, 21.05% below the high.
€9.70+€0.20 (+2.11%)
Icape Holding S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.41% below the high.
€23.90+€0.40 (+1.7%)
We.Connect S.A.’s quoted price sits in the lower half of its reported 52-week range, 19.26% below the high.
€3.88+€0.07 (+1.84%)
Guillemot Corporation S.A.’s quoted price sits in the lower half of its reported 52-week range, 25.1% below the high.
€9.15+€0.01 (+0.11%)
Groupe LDLC S.A.’s quoted price sits in the lower half of its reported 52-week range, 55.58% below the high.
€1.81€0.00 (0.0%)
Facephi Biometria, S.A.’s quoted price sits in the lower half of its reported 52-week range, 37.15% below the high.